Polyclonal autoantibodies against C1 inhibitor in a case of acquired angioedema

Annals of Allergy, Asthma and Immunology

Volumn 88, Issue 6, 2002, Pages 632-637

  Ponce, Isabel M ^a   Caballero, Teresa ^a   Reche, Marta ^a   Piteiro, Ana B ^a   López Serrano, M Concepción ^a   Fontán, Gumersindo ^a   López Trascasa, Margarita ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; AUTOANTIBODY; COMPLEMENT COMPONENT C1S INHIBITOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; POLYCLONAL ANTIBODY; PROTEIN G; STANOZOLOL; TRANEXAMIC ACID;

AFFINITY CHROMATOGRAPHY; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HUMAN; IMMUNOASSAY; MALE; PRIORITY JOURNAL;

EID: 0036627714     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61896-0     Document Type: Article

References (20)

1. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Ann Rev Biochem 1983;52:655-709.
2. Davis AE III. C1 inhibitor and hereditary angioneurotic edema. Annu Rev Immunol 1988;66:595-628.
3. Caldwell JR, Ruddy S, Schur PH, Austen KF. Acquired C1 deficiency in lymphosarcoma. Clin Immunol Immunopathol 1972;1:39-52.
4. Jackson J, Sim RB, Whelan A, Feighery C. An IgG autoantibody which inactivates C1-inhibitor. Nature 1986;323:722-724.
5. Cicardi M, Beretta A, Colombo M, et al. Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema. Clin Exp Immunol 1996;106:475-480.
6. Späth PJ, Wüthrich B. Inherited and acquired deficiencies of C1 esterase inhibitor in humans. In: Rother K, Till GO, Hänsch GM, editors. The Complement System. New York: Springer-Verlag, 1998;353-410.
7. de Smet BJ, de Boer JP, Agterberg J, et al. Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats. Blood 1993;81:56-61.
8. Phimister GM, Whaley K. Measurement of complement. In: Gooi HC, Chapel H, editors. Clinical Immunology: A Practical Approach. New York: IRL Press, 1990;81-109.
9. Keir G, Luxton RW, Thompson EJ. Isoelectric focusing of cerebrospinal fluid immunoglobulin G: an annotated update. Ann Clin Biochem 1990;27:436-443.
10. Verpy E, Couture-Tosi E, Eldering E, et al. Crucial residues in the carboxyterminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function. J Clin Invest 1995;95:350-359.
11. Alsenz J, Bork K, Loos M. Autoantibody-mediated acquired deficiency of C1 inhibitor. N Engl J Med 1987;316:1360-1366.
12. Malbran A, Hammer CH, Frank MM, Fries LF. Acquired angioedema: observations on the mechanism of action of autoantibodies directed against C1 esterase inhibitor. J Allergy Clin Immunol 1988;81:1199-1204.
13. Jackson J, Sim RB, Whaley K, Feighery C. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema. J Clin Invest 1989;83:698-707.
14. Salvesen GS, Catanese JJ, Kress LF, Travis J. Primary structure of the reactive site of human C1-inhibitor. J Biol Chem 1985;260:2432-2436.
15. van der Graaf F, Koedam JA, Griffin JH, Bouma BN. Interaction of human plasma kallikrein and its light chain with C1 inhibitor. Biochemistry 1983;22:4860-4866.
16. Zuraw BL, Curd JG. Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients. J Clin Invest 1986;78:567-575.
17. Whaley K, Sim RB, He S. Autoimmune C1-inhibitor-deficiency. Clin Exp Immunol 1996;106:423-426.
18. Cicardi M, Bisiani G, Cugno M, et al. Autoimmune C1 inhibitor deficiency: report of eight patients. Am J Med 1993;95:169-175.
19. Cugno M, Cicardi M, Agostoni A. Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid. J Allergy Clin Immunol 1994;93:870-876.
20. Donaldson VH, Bernstein DI, Wagner CJ, et al. Angioneurotic edema with acquired C1-inhibitor deficiency and autoantibody to C1-inhibitor: response to plasmapheresis and cytotoxic therapy. J Lab Clin Med 1992;119:397-406.